[1] 中华人民共和国卫生部.中国居民营养与健康状况[J].中国心血管病研究杂志,2004,2(12):919-922.
[2] Johansson M,Elam M,Rundqvist B,et a1.Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension[J].Hypertension,2000, 36(4):543-548.
[3] 比索洛尔多中心研究协作组.国产比索洛尔对高血压2型糖尿病患者糖代谢的影响[J].中华内科杂,2005,44(7):503-505.
[4] 牟建军. 起始联合治疗在中国高血压患者治疗中的地位[J].中华高血压杂志,2011,19(3):205-206.
[5] Su VY,Chang YS,Hu YW,et al.Carvedilol, bisoprolol,and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease[J].Medicine (Baltimore), 2016,95(5):e2427.
[6] Cheng XW,Okumura K,Kuzuya M,et al.Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers[J].J Cardiovasc Pharmacol,2009,54(1):47-56.
[7] Ji T,Feng C,Sun L,et al.Are beta-blockers effective for preventing post-coronary artery bypass grafting atrial fibrillation? Direct and network meta-analyses[J].Ir J Med Sci,2016, 185(2):503-511.
[8] Han SW,Choi SW,Ryu KH,et al.Beneficial effect on surrogate markers of heart failure with bisoprolol up-titration to recommended targets in Korean patients with heart failure and left ventricular systolic dysfunction[J].Cardiovasc Ther,201634(3):172-179.
[9] 钟鸿,蔡文阳,郭健滨,等.比索洛尔联合依那普利治疗原发性高血压及肾实质性高血压的疗效观察[J].中国实用医药,2015,10(17):167-169.
[10] Paterna S,Parrinello G,Di Pasquale P,et al.Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension[J].Adv Ther,2007,24(6):1260-1270.
[11] Castagno D,Jhund PS,McMurray JJ,et al.Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial[J].Eur J Heart Fail,2010,12(6):607-616.
[12] 陈立萍. 苯磺酸氨氯地平与比索洛尔治疗高血压疗效[J].中国当代医药,2014,17(6):159.
[13] 方宁远,陆惠华,李卫菊,等.氨氯地平治疗老年高血压的临床研究[J].高血压杂志,1999,7(1):63.
[14] Parati G, Ochoa JE, Lombardi C, et al.Assessment and management of blood-pressure variability[J].Nat Rev Cardiol,2013,10(3): 143-155.
[15] Wang JG, Yan P, Jeffers BW.Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability:Evidence from randomized controlled trials[J]. JMSH, 2014,8(5):340-349.
[16] 王磊,魏新伟,于芳.不同降压药物联合治疗对老年高血压患者血压变异性的影响[J].天津医药,2016,44(1):105-109.
[17] Chavanu K, Merkel J, Quan AM.Role of ambulatory blood pressure monitoring in the management of hypertension[J].Am J Health Syst Pharm,2008,65(3):209-218.
[18] Dolan E,Stanton A,Thijs L.Superiority of ambulatory over clinic blood pressure measurement in predicting mortality:the Dublin outcome study[J].Hypertension,2005,46(1):156-161.
[19] Mullè G,Cottone S,Cusimano P,et al.Inverse relationship between ambulatory arterial stiffness index and glomerullar filtration rate in arterial hypertension[J].Am J Hypertes, 2010,21(1):35-40.
[20] Peng T,Hu Z,Guo L,et al.Renal protective effects of benidipine and valsartan in primary hypertension patients with proteinuria[J].Zhonghua Xin Xue Guan Bing Za Zhi,2010,38(1):20-22.
[21] Abe M,Okada K,Maruyama N.Benidipine reduces albuminuria and plasma aldosterone in mild-to- moderate stage chronic kidney disease with albuminuria[J].Hypertens Res,2011,34(2):268-273.
[22] Nakamura T,Sato E,Fujiwara N,et al.Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG,urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease[J].Am J Med Sci,2010,339(2):157-163.
[23] Gradman AH,Parise H,Lefebvre P,et al.Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients:a matched cohort study[J].Hypertension, 2013,61(2):309-318.
[24] Ong HT.Beta blockers in hypertension and cardiovascular disease[J].BMJ,2007,334(7600):946-949.
[25] Hostalek U,Czarnecka D,Koch EM.Treatment of hypertensive patients with a fixed-dose combination of bisoprolol and amlodipine:results of a cohort study with more than 10,000 patients[J].Cardiol Ther,2015,4(2):179-190. |
